SpecificationsOrganism/cell line/tissue*Mus musculus*SexFemalesSequencer or array typeAffymetrix Mouse430A microarray chipData formatRaw data normalizedExperimental factorsLy6D^−^ CLPs derived from osteocalcin + cells depleted mice versus wildtype littermates.Experimental features20,000--30,000 Ly6D^−^ CLPs derived from either osteocalcin + cells depleted mice (OcnCre^+^;iDTR mutant) or control littermates (OcnCre^−^;iDTR) were isolated from the bone marrow by flow cytometry and subjected to microarray comparison of global gene expression. Mice were 6--8 weeks old. Three replicates were used for each experimental condition.ConsentAllowed to reuse citing original author.Sample source locationNA

1. Direct link to deposited data {#s0005}
================================

<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66102>.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Mouse models {#s0015}
-----------------

To specifically delete mature osteolineage cells, the OC-*cre* strain (from Dr. Thomas L. Clemens, Johns Hopkins University, MD, USA) [@bb0010], which expressed Cre under the *Osteocalcin* promoter was crossed to the iDTR strain [@bb0015]. Temporally controlled cell ablation was achieved upon injection of diphtheria toxin into the OcnCre^+/−^;iDTR strain [@bb0005]. To study the effect of Ocn^+^ cells on hematopoiesis, OcnCre^+/−^ injected with diphtheria toxin or OcnCre^+/−^;iDTR injected with PBS served as controls while OcnCre^+/−^;iDTR injected with diphtheria toxin were used as mutants. For most experiments, 25 ng diphtheria toxin in PBS/g of body weight was injected daily into both control and mutant animals for 28 days from 4 weeks of age to achieve an acute deletion of specific osteolineage populations. Mice were harvested for analysis the next day after the last dose of diphtheria injection. For all experiments, littermates were used as controls. All animal usage and procedures performed were approved by the Institutional Animal Care and Use Committee of Massachusetts General Hospital.

3. Flow cytometry {#s0020}
=================

Before sacrifice, peripheral blood was collected from each mouse and subjected to complete blood cell count. For each mouse, tibiae, femurs, iliac crests, spines, ulnae, radii, and humeri were collected for bone marrow cells. In addition, spleen and thymus were also collected for lymphocyte staining. Changes in hematopoietic populations were quantified by flow cytometry. Bone marrow cells harvested from each animal were counted. We routinely stain 5 × 10^7^ cells per sample for the hematopoietic stem population, and 1 × 10^7^ cells per sample for each progenitor and mature population. Lineage cocktail consists of biotinylated B220, CD3e, CD4, CD8a, CD19, CD11b, Gr1, Ter119, CD11c, and NK1.1 antibodies. Fluorescence conjugated to streptavidin was used to recognize lineage cocktail. The following antibody combinations were used to recognize Ly6D^−^ CLP (Lineage-Pacific Orange, Sca-Pacific Blue, cKit-APC-Cy7, CD127-PE-Cy7, Thy1.2-FITC, Ly6D-APC).

4. Microarrays {#s0025}
==============

Ly6D^−^ CLPs were sorted from 6 to 8 weeks old OcnCre;iDTR mutants and controls using the FACSAria following daily DT treatment for 4 weeks. RNA was extracted using the TRIzol® (Invitrogen) according to the manufacturer\'s instructions. Samples were processed by the NuGen Ovation V2 laboratory Process in the microarray core facility of Dana-Farber Cancer Institute. Briefly, first stand cDNA was prepared from total RNA using a DNA/RNA chimeric primer and a reverse transcriptase. The resulting double stranded cDNA with a unique heteroduplex at the 5\' end of the antisense strand were amplified using SPIATM amplification, a repeated process of SPIATM DNA/RNA primer hybridization, DNA replication, strand displacement and RNA cleavage which resulted in a rapid accumulation of cDNA with sequence complementary to the original RNA. The SPIATM amplified cDNA was purified using the Zymo Research DNA Clean & Concentrator™ system. The purified cDNA was fragmented through a chemical and enzymatic process and labeled via enzymatic attachment of a biotin-labeled nucleotide to the 3′-hydroxyl end of the fragmented cDNA. The biotinylated cDNA was added to a hybridization solution containing several biotinylated control oligonucleotides (for quality control), and hybridized to the Mouse430A microarray chip overnight at 45 °C. The chips were then transferred to a fluidics instrument that performs washes to remove cDNA that has not hybridized to its complementary oligonucleotide probe. The bound cDNA was then fluorescently labeled using phycoerythrin-conjugated streptavidin (SAPE); additional fluors were then added using biotinylated anti-streptavidin antibody and additional SAPE. Each cDNA bound at its complementary oligonucleotide was excited using a confocal laser scanner, and the positions and intensities of the fluorescent emissions were captured. These measures provide the basis of subsequent biostatistical analysis.

5. Quality assessment {#s0030}
=====================

Standard QA/QC analyses involved chip analysis with the assayQualityMetrics BioConductor package and found no significant quality issues with any of the chips, as determined by (among other methods) visual inspection, intensity distributions or RNA degradation plots. The data was background corrected and normalized with RMA (Robust Multichip Average) using the "affy" BioConductor package. Values in the data matrix represent log2 normalized intensity values.

6. Differential expression quantification and classification {#s0035}
============================================================

The selected database comprises 6 expression measurements of 41,345 genes, 3 in the first condition and 3 in the second. The recorded expression values ranged between 4.023 and 10,198.29. Supervised learning or class prediction methods were used for molecular classification and pattern recognition. This analysis involves selecting the features (genes) most correlated with a phenotypic distinction of interest. These features or "marker genes" are biologically interesting in themselves but they can also be used as the input of a classification algorithm that uses existing "labeled" samples to build a model to predict the labels for future samples. Genes correlated with a binary class distinction, for example a morphological or clinical phenotype, is directly identified and selected by using a "distance" metric, for example t-test statistic = (mA − mB) ÷ (s2A + s2B) \[m and s are the means and std. dev. per class\] or Signal to noise ratio = (mA − mB) / (sA + sB) \[m and s are the means and std. dev. per class\]. Our analysis generated 400 selected differential genes. [Fig. 1](#f0005){ref-type="fig"} is a color map illustrating 30 genes overexpressed in mutant Ly6D^−^ CLPs compared to control Ly6D^−^ CLPs. [Table 1](#t0005){ref-type="table"} shows the mean, standard deviation, score, and fold change of the 30 genes.
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![Heat map illustration of 30 differential genes among the 400 genes identified when comparing the transcriptome of T competent progenitors (Ly6D^−^ CLPs) isolated from Ocn^+^ deleted mice compared to control littermates. Red represents overexpression whereas blue means lower expression.](gr1){#f0005}

###### 

List of 30 genes overexpressed in mutant Ly6D- CLPs compared to control Ly6D- CLPs.

  Accession   T-test    P value   FDR      Fold change   Description
  ----------- --------- --------- -------- ------------- --------------------
  17523486    26.2253   0         0.8156   1.1068        Zfp105
  17208361    19.9693   0.0001    0.8156   1.2735        --
  17399895    15.5519   0.0025    0.8156   1.113         Sprr2k
  17264448    13.6163   0.0032    0.8156   1.1092        Arhgef15
  17512177    13.5854   0.0028    0.8156   1.4664        ENSMUST00000153288
  17391347    13.4535   0.0002    0.8156   1.2012        Nphp1
  17494714    12.2023   0.0005    0.8156   1.208         Olfr710
  17544210    12.0084   0.0015    0.8156   1.1814        ENSMUST00000158796
  17347443    11.084    0.002     0.8156   1.2347        Gm10494
  17533124    10.7079   0.0006    0.8156   1.2265        Ssxb9
  17305243    9.913     0.0097    0.8156   1.2408        Sftpd
  17254041    9.4857    0.0008    0.8156   1.5203        Ccl2
  17259689    9.2744    0.0077    0.8156   1.301         AK079017
  17307801    9.0039    0.0012    0.8156   1.2928        Gulo
  17430674    8.9262    0.0024    0.8156   1.4329        ENSMUST00000152128
  17312223    8.9021    0.0009    0.8156   1.307         BC025446
  17548581    8.7592    0.0016    0.8156   1.2293        Gm3257
  17219374    8.6936    0.001     0.8156   1.2858        Alyref2
  17302289    8.456     0.0048    0.8156   1.1399        Pcdh17
  17466729    8.4263    0.0056    0.8156   1.2631        4921507P07Rik
  17475498    8.3725    0.0085    0.8156   1.1133        Cyp2f2
  17529871    8.0847    0.0026    0.8156   1.1418        Acpl2
  17432985    8.0258    0.0022    0.8156   1.3174        ENSMUST00000138492
  17467548    7.9069    0.01      0.8156   1.0905        Igkv6-14
  17232499    7.8339    0.002     0.8156   1.2085        Rsph4a
  17550502    7.6586    0.0035    0.8156   1.1793        17.94637
  17286115    7.6359    0.0087    0.8156   1.3329        Prl3d1
  17423885    7.5189    0.0032    0.8156   1.2563        Gm136
  17433901    7.5064    0.0151    0.8156   1.1834        Tas1r3
  17407496    7.2659    0.011     0.8156   1.2624        Crct1
